Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients
International Journal of Urology · 2026
DOI: 10.1111/iju.70634 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Urology, 2026. Verfasst von Takafumi Yanagisawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Urinary Bladder Neoplasms, Postoperative Complications, Cystectomy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To evaluate perioperative safety, pathological outcomes, and oncological outcomes of en bloc resection of bladder tumor (ERBT) in a large multicenter real‐world cohort.
Methods
We retrospectively analyzed 668 patients who underwent ERBT at five institutions. Perioperative and pathological outcomes were assessed in the overall cohort. Recurrence‐free survival (RFS) was evaluated in patients with pathologically confirmed non‐muscle‐invasive bladder cancer (NMIBC) without a history of upper tract urothelial carcinoma ( n = 551). Clinicopathological prognosticators of recurrence were identified using Cox proportional hazards regression.
Results
The median age was 73 years, and the median maximum tumor diameter was 15 mm. The median operative time and postoperative catheterization period were 48 min and 3 days, respectively. Perioperative complications occurred in 60 patients (9.0%), including eight (1.2%) with Clavien–Dindo Grade III or higher complications. Detrusor muscle was identified in 77.2% of evaluable specimens. Final pathology showed pTa, pT1, pTis, and pT2 disease in 377 (56.4%), 239 (35.8%), 16 (2.4%), and 25 patients (3.7%), respectively. With a median follow‐up of 42 months, the estimated 1‐, 2‐, and 5‐year RFS rates were 80.9%, 73.2%, and 57.1%, respectively. RFS did not differ significantly between pTa and pT1 disease (log‐rank p = 0.39). Patients presenting with recurrent tumors had a significantly higher risk of subsequent intravesical recurrence than those with primary tumors (HR 2.06, 95% CI 1.38–3.07; p < 0.001).
Conclusions
ERBT demonstrated favorable perioperative safety and acceptable oncological outcomes in this large multicenter cohort. Post‐ERBT recurrence remained strongly influenced by prior recurrence history, highlighting the importance of risk‐adapted postoperative management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Urology, National Hospital Organization Ureshino Medical Center, Saga, Japan.
- Department of Urology, Saitama Medical Center, Saitama, Japan.
- Department of Urology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
ORCID-Profile: Takafumi Yanagisawa, Akihiro Matsukawa, Yohei Okada, Risa Kubota, Kagenori Ito, Jun Miki, Takahiro Kimura
Zitieren
APA
Yanagisawa, T., Matsukawa, A., Iwatani, K., Hayashida, Y., Okada, Y., Kubota, R., Kamikubo, K., Taneda, Y., Kondo, H., Ito, K., Miki, J., Kimura, T., & Japanese En bloc TUR (JET) Study Group (2026). Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients. International Journal of Urology. https://doi.org/10.1111/iju.70634
Vancouver
Yanagisawa T, Matsukawa A, Iwatani K, Hayashida Y, Okada Y, Kubota R, et al. Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients. International Journal of Urology. 2026. doi:10.1111/iju.70634
BibTeX
@article{Yanagisawa2026,
author = {Yanagisawa, Takafumi and Matsukawa, Akihiro and Iwatani, Kosuke and Hayashida, Yasushi and Okada, Yohei and Kubota, Risa and Kamikubo, Kiichi and Taneda, Yuki and Kondo, Hirotaka and Ito, Kagenori and Miki, Jun and Kimura, Takahiro and Japanese En bloc TUR (JET) Study Group, Japanese En bloc TUR (JET) Study Group},
title = {Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70634}
}
EUVIMED